Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer

Gynecologic Oncology

Volumn 81, Issue 1, 2001, Pages 71-76

  Gerçel Taylor, Çiçek ^a   Bazzett, Lisa B ^a   Taylor, Douglas D ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

IgG glycosylation; Ovarian cancer; Tumor reactive antibodies

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN G; OLIGOSACCHARIDE;

ADULT; ANTIBODY DETECTION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0035056217     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6102     Document Type: Article

References (28)

1. Antigens and antibodies in malignant melanoma
2. Autoantibodies to 90kD heat-shock protein in sera of breast cancer patients
3. Prognostic significance of autoantibodies to laminin in the sera of breast cancer patients
4. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration
5. "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients
6. Immunologic characterization of tumor markers in human ovarian cancer cell lines
7. Identification of antigenic components recognized by "membrane bound" antibodies from ovarian cancer patients
8. Humoral immunity against a tandem repeat epitope of human mucin muc-1 in sera from breast, pancreatic and colon cancer patients
9. Human T lymphocytes recognize a peptide of single point mutated oncogenic Ras proteins
10. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
11. Breast and ovarian cancer specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide
12. Identification of antigenic epitopes of cathepsin D recognized by the humoral response of ovarian cancer patients
13. Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography
14. Revised anti-cancer serological response: Biological significance and clinical implications
15. Analysis of the anti-p53 antibody response in cancer patients
16. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients
17. Cathepsin D and glucose-regulated protein 78 recognized by the humoral response of ovarian cancer patients
18. Nonprecipitating asymmetric antibodies
19. Are the non-precipitating asymmetric antibodies autoprotecrive and regulatory antibodies?
20. Isolation and characterization of an ovarian carcinoma cell line as a model for drug resistance
21. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
22. Binding of specific peroxidase-labeled antibody to placental-type alkaline phosphatase on tumor-derived membrane fragments
23. Cancer immunology: The search for specificity - G. H. A. Clowes Memorial lecture
24. Tumor reactive immunoglobulins
25. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface
26. Autoantibodies in viral hepatitis related hepatocellular carcinoma
27. Analysis of oligosaccharides involved in the asymmetrical glycosylation of IgG monoclonal antibodies
28. Preferential synthesis of asymmetric antibodies in rats immunized with paternal particulate antigens: Effect on pregnancy